Welcome to our dedicated page for Babcock & Wilcox Enterprises SEC filings (Ticker: BWSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Babcock & Wilcox Enterprises's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Babcock & Wilcox Enterprises's regulatory disclosures and financial reporting.
Babcock & Wilcox Enterprises, Inc. reported that its Board of Directors has authorized a debt repurchase program for its outstanding 8.125% Senior Notes due 2026 and 6.50% Senior Notes due 2026. The company may buy back any or all of the remaining principal amounts of these notes over time.
The notes can be repurchased through open market purchases, privately negotiated transactions, Rule 10b5-1 trading plans or other techniques. The authorization does not require a minimum amount of repurchases and can be modified, suspended or terminated at any time, with actual activity depending on trading prices, market conditions and other corporate considerations.
Christopher S. Riker, Chief Operating Officer of Babcock & Wilcox Enterprises, Inc. (BWSN), reported equity activity tied to vested restricted stock units. On 08/25/2025 a grant of 174,000 restricted stock units vested and converted into an equivalent number of common shares.
Following the vesting, the filing shows 174,000 common shares acquired at a reported price of $1.72 per share and 78,909 shares were withheld by the issuer to satisfy tax withholding obligations related to the award, leaving the reporting person with 222,088 directly held shares. The filing also reports 300,997 shares owned directly after a separate acquisition entry and 329,793 shares held indirectly in a 401(k) plan. The Form 4 is signed by an attorney-in-fact on 08/26/2025.
Cameron M. Frymyer, Chief Financial Officer of Babcock & Wilcox Enterprises, Inc. (BWSN), reported an insider purchase of common stock. The Form 4 shows a purchase on 08/19/2025 of 20,000 shares at a price of $1.55 per share, increasing his beneficial ownership to 153,805 shares. The filing was signed by an attorney-in-fact on 08/20/2025. No derivative transactions were reported and no other material details are provided.
Babcock & Wilcox Enterprises, Inc. (BWSN) reporting person Kenneth M. Young, who serves as Chief Executive Officer and a director, is shown on this Form 4 as having purchased 20,000 shares of the issuer's common stock on 08/18/2025 at a price of $1.5071 per share. The filing reports that following the reported transaction the reporting person beneficially owns 261,745 shares indirectly, with those shares held of record by the Kenneth M. Young Revocable Trust U/A 5/8/15. The form is signed by an attorney-in-fact on behalf of Mr. Young on 08/19/2025. The filing also lists a separate entry showing 1,442,787 shares disposed (D) on the form record. No additional context, dates or prices for that disposal entry are provided in the text of this Form 4.
Babcock & Wilcox Enterprises, Inc. furnished information about the expiration and results of its previously announced cash tender offers for certain debt. The company had offered to purchase up to a maximum $70 million aggregate amount of its 8.125% Senior Notes due 2026 and 6.50% Senior Notes due 2026. The details are provided in a press release dated August 15, 2025, furnished under Regulation FD as an exhibit to this report.
Babcock & Wilcox Enterprises, Inc. received a joint Schedule 13G/A disclosing that six related reporting persons collectively hold 4,332,913 shares of the issuer's common stock, representing 4.4% of the class. The filers are CastleKnight Master Fund LP, CastleKnight Fund GP LLC, CastleKnight Management LP, CastleKnight Management GP LLC, Weitman Capital LLC and Aaron Weitman. Each reporting person reports zero sole voting or dispositive power and reports shared voting and dispositive power over 4,332,913 shares, and they certify the holdings are not for the purpose of changing or influencing control of the issuer. The filing attaches a joint filing agreement and a control-person identification exhibit.
Babcock & Wilcox Enterprises, Inc. filed a Form 4 reporting that Kenneth M. Young, who is listed as both a director and the Chief Executive Officer, was granted 150,000 restricted stock units (RSUs) on 08/07/2025 under the company's Amended and Restated Long-Term 2021 Incentive Plan. Each RSU represents a contingent right to receive one share of the company's common stock.
The RSUs are recorded with a $0 conversion/exercise price and are shown as 150,000 derivative securities beneficially owned following the transaction. Vesting is stated to occur in three annual installments beginning August 7, 2026. The Form 4 was signed by an attorney-in-fact on 08/11/2025.
Babcock & Wilcox Enterprises, Inc. reported a grant of 100,000 restricted stock units (RSUs) to Jimmy B. Morgan, who is identified as the company's Chief Commercial Officer. The RSUs represent a contingent right to receive one share of the company's common stock for each RSU and are issued under the company's Amended and Restated Long-Term 2021 Incentive Plan.
The transaction date listed is 08/07/2025 and the reporting table shows 100,000 RSUs beneficially owned following the transaction in a direct ownership form. The RSUs vest in three annual installments beginning August 7, 2026.
Babcock & Wilcox Enterprises granted 115,000 restricted stock units to Chief Financial Officer Cameron M. Frymyer on 08/07/2025 under the Amended and Restated Long-Term 2021 Incentive Plan. Each RSU represents a contingent right to receive one share of the companys common stock. The grant is exercisable as RSUs that vest in three annual installments beginning August 7, 2026. The Form 4 reports 115,000 derivative securities beneficially owned following the transaction in a direct ownership form and was signed by an attorney-in-fact on 08/11/2025.
John J. Dziewisz, General Counsel & Secretary of Babcock & Wilcox Enterprises, Inc. (BWSN), reported both a small open‑market sale and a large restricted stock unit grant. On 08/07/2025 he sold 2,915 shares of common stock at $1.34 per share pursuant to a Rule 10b5‑1 trading plan, leaving him with 239,381 shares held directly. The filing also reports an award of 115,000 restricted stock units (RSUs) under the company’s Amended and Restated Long‑Term 2021 Incentive Plan; each RSU represents a contingent right to one share.
The RSUs vest in three annual installments beginning on August 7, 2026, which ties the grant to multi‑year retention. The sale was executed under an established trading plan rather than as an ad hoc disposition.